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Odontogenic tumors originate from the remains of
migrating enamel epithelium after the completion of
normal tooth genesis. These enamel epithelium rem-
nants exhibit the ability to recapitulate the events that
occur during tooth formation. Several lines of evi-
dence suggest that aberrance in the signaling path-
ways similar to the ones that are used during tooth
development, including the WNT pathway, might be
the cause of odontogenic tumorigenesis and mainte-
nance. In this study we demonstrated that WNT5A
expression was intense in both the epithelial compo-
nent of ameloblastomas, the most common epithelial
odontogenic tumor, and in this tumor’s likely precur-
sor cell , the enamel epithelium located at the cervical
loop of normal developing human tooth buds. Addi-
tionally, when WNT5A was overexpressed in enamel
epithelium cells (LS-8), the clones expressing high
levels of WNT5A (S) exhibited characteristics of tu-
morigenic cells, including growth factor indepen-
dence, loss of anchorage dependence, loss of contact
inhibition, and tumor formation in immunocompro-
mised mice. Moreover, overexpression of WNT5A dras-
tically increased LS-8 cell migration and actin reorgani-
zation when compared with controls. Suppression
of endogenous WNT5A in LS-8 cells (AS) greatly im-
paired their migration and AS cells failed to form signif-
icant actin reorganization and membrane protrusion
was rarely seen. Taken together , our data indicate
that WNT5A signaling is important in modulating
tumorigenic behaviors of enamel epithelium cells
in ameloblastomas. (Am J Pathol 2010, 176:461–471;
DOI: 10.2353/ajpath.2010.090478)
Odontogenic tumors comprise a group of lesions in the
oral and maxillofacial region, ranging from benign to
malignant neoplastic tissue. Similar to normal odontogen-
esis, odontogenic tumors exhibit characteristics of epi-
thelium-mesenchyme interactions that occur during tooth
genesis. After the formation of the tooth crown, enamel
epithelium cells at the cervical loop directionally prolifer-
ate to the root area. After tooth formation is completed,
these enamel epithelium cells are left in the periodontal
ligament space and are believed to give rise to several
epithelial odontogenic tumors.1,2 According to the World
Health Organization in 2005, odontogenic tumors are
classified in relation to their tissues of origin into epithe-
lial, epithelial-ectomesenchymal, and ectomesenchymal
neoplasms.3
Ameloblastoma, a usually benign but locally invasive
tumor, is the most common odontogenic tumor derived
from odontogenic epithelium. It is slow growing but has
persistent growth that produces marked deformity of the
face. The term “ameloblastoma” is derived from the his-
tology of the tumor that resembles the developing enamel
organ of the tooth germ.4,5 Ameloblastoma has a high
recurrence rate (50 to 90%); therefore, wide surgical
resection is the preferred treatment. The molecular deter-
minants driving initiation and maintenance of ameloblas-
toma remain unclear. Evidence suggests that alteration in
signaling pathways that are important for normal tooth de-
velopment such as tumor necrosis factor, fibroblast growth
factor, Sonic Hedgehog, and wingless-type (WNT) path-
ways could contribute to the etiology of ameloblastoma.6–9
WNT5A (wingless-type MMTV integration site family,
member 5A) belongs to the WNT family that controls
several processes during embryogenesis including cell
fate specification, tissue patterning, cell proliferation, cell
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differentiation, and cell migration.10 While WNT5A also is
implicated to play an important role in a variety of can-
cers, the function of WNT5A in tumorigenesis is obscure
and contradictory.11 Evidence suggests that WNT5A
possesses oncogenic properties and that WNT5A en-
hances the aggressive and malignant behaviors of cells
in malignant melanoma,12 gastric cancer, lung cancer,13
and prostate cancer.14,15 On the other hand, WNT5A has
been considered a tumor suppressor in neuroblastoma,
acute myeloid leukemia, and primary dukes B colon can-
cer.16–18 In the case of odontogenic tumors, WNT5A
expression in ameloblastoma has been reported,19 but
its biological consequence has not been explored.
In the present study, we demonstrate strong WNT5A
expression in the epithelial compartment of human
ameloblastomas and in the enamel epithelium cells at the
cervical loop during normal human tooth development.
Furthermore, when overexpressed in enamel epithelium
cells, LS-8, WNT5A promotes cell survival, instilling a loss
of contact inhibition, loss of anchorage dependence, and
increased tumor formation rate in nude mice. Overex-
pression of WNT5A also enhances cell migration, in-
creases actin reorganization and filopodia/lamellipodia
formation in LS-8 cells. Our results demonstrate that
WNT5A overexpression has multiple effects on enamel
epithelium cell behaviors that are all important character-
istics of tumorigenic cells.
Materials and Methods
Samples Collection
Human tissue samples were obtained according to the
institutional review board approved protocols. First oc-
currence, multicystic/solid ameloblastomas, were col-
lected through the Oral Pathology Service at the Univer-
sity of North Carolina from 1998 to present. Tumors were
obtained along with the patients’ clinicopathological and
demographic data. Human primary tooth germs from
10th- to 19 6/7th-week-old fetus were obtained from
patients undergoing abortion through the University of
North Carolina Department of Obstetrics and Gynecol-
ogy. Any fetuses with known genetic anomalies or
medical conditions were excluded. All tissue samples
were fixed in formalin, embedded in paraffin, and used
for immunohistochemistry.
Immunohistochemistry
Goat anti-mouse WNT5A polyclonal antibody (1:200) and
recombinant mouse WNT5A were obtained from R and D
Systems (Minneapolis, MN). Specificity and the sensitivity
of anti-WNT5A antibody were tested on mouse small
intestine, hair follicles, and liver paraffin-embedded sec-
tions. Immunohistochemical staining was performed on
4-m thick, paraffin-embedded sample sections by using
the Elite Vectastain kit (Vector Laboratories, Burlingame,
CA). Deparaffinized sections were blocked with normal se-
rum and then incubated with anti-WNT5A antibody (1:200)
at 4°C overnight. A biotinylated rabbit anti-goat antibody
was used as the secondary antibody, and immunore-
action was visualized by using the 3, 3-diaminobenzi-
dine substrate kit for peroxidase (Vector Laboratories).
Sections were counterstained with hematoxylin and
evaluated for immunoreactivity.
Cell Culture
Mouse enamel epithelium cells established by immortal-
izing primary cultures of new born mouse enamel epithe-
lium with Simian virus 40 large T antigen, LS-8 (gener-
ously provided by Dr. Malcolm Snead, University of
Southern California), were cultured as previously de-
scribed.20 Briefly, the cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM; Sigma-Aldrich, St.
Louis, MO) supplemented with 10% fetal bovine serum
(FBS) (Gibco, Carlsbad, CA) and 100 U/ml penicillin and
100 g/ml streptomycin (Gibco). Culture medium was
replaced twice weekly.
Isolation of Wnt5a cDNA and Constructs
Generation
Total RNA was isolated from mouse kidney by using
TRIzol reagent (Invitrogen, Carlsbad, CA). Two micro-
grams of total RNA was used for reverse transcription
(RT) and the cDNA was synthesized by using the Super-
script RT kit (Invitrogen) followed by PCR with primers
specific for full-length mouse Wnt5a. Primer sequences
were as follows: 5-CACCATGAAGAAGCCCATTGG-3
and 5-TTTGCACACGAACTGATC C-3. The PCR prod-
ucts were verified and confirmed the expected size at
1140 bp. The Wnt5a-PCR products were then ligated into
pcDNA3.1 V5-His-TOPO vector (Invitrogen) by using the
TOPO TA cloning kit (Invitrogen). The molecular weight of
the ligated insert was analyzed by restriction enzymes Hin-
dIII and XhoI (New England Biolabs, Ipswich, MA). Plas-
mids were then analyzed by sequencing at the University of
North Carolina, Chapel Hill, DNA sequencing facility.
Transfection and Stable Clone Establishment
The sense, antisense constructs (pcDNA3.1/Wnt5a
and pcDNA3.1/ASWnt5a) or pcDNA 3.1/V5-HisA vector
(empty vector [EV]) (Invitrogen), were transfected into
LS-8 cell by using Fugene 6 (Roche Applied Science,
Indianapolis, IN). After 48 hours, cells were trypsinized
and plated at a low density. Cells were maintained and
selected in the presence of Geniticin (600 g/ml) (G418,
Invitrogen) for up to 3 to 4 weeks. Single-cell derived
stable clones were prepared by cloning rings and the
expression of WNT5A from each clone was analyzed by
Western blot.
Triton X-114 Phase Separation and Western
Blot Analysis
To ensure the WNT5A secretion from stable clones, sep-
aration of Wnt5a in conditioned medium was performed
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according to the protocol for WNT3A separation with
modification.21 In brief, conditioned medium collected
from stable clones was mixed 1:1 with ice cold 4.5%
Triton X-114, 150 mmol/L NaCl, 10 mmol/L Tris-HCl, pH
7.5, incubated on ice for 5 minutes, then at 31°C for 5
minutes, and centrifuged at 2000  g at 31°C for 5
minutes. Equal volumes of detergent and aqueous
phases of Triton X-114 were then evaluated for the pres-
ence of WNT5A by using Western blot.
Since the majority of secreted WNT5A was bound to
the proteoglycans component of extracellular matrices,22
WNT5A bound to extracellular matrices and cell surface
were collected, normalized against -actin, and used to
compare the level of WNT5A expression. Cells were
washed twice with PBS and gently lysed in lysis buffer
(20 mmol/L Tris-HCl, pH 7.5, 0.5 mmol/L MgCl2, 0.1%
TritonX-100) containing the P1860 protease inhibitor
cocktails (Sigma-Aldrich). The supernatant was collected
for analysis. Equal volumes of each sample for Western blot
were dissolved in SDS sample buffer in the presence of 10
mmol/L dithiothreitol, separated by SDS-polyacrylamide gel
electrophoresis (Invitrogen), and transferred to nitrocellu-
losemembrane (Biorad, Hercules, CA). WNT5A protein was
detected by anti-WNT5A antibody (R and D Systems) (1
g/ml), and the anti-goat conjugated with horseradish perox-
idase (Santa Cruz Biotechnology, Santa Cruz, CA) was used
as a secondary antibody. -actinwasdetectedby anti- -actin
antibody (Cell Signaling, Danvers, MA) and the secondary
antibody, anti-rabbit conjugated with horseradish peroxidase
(Cell Signaling). The immunoreactivity was visualized by using
the ECL Plus kit (GE Health care, Piscataway, NJ).
Quantitative Real-Time PCR
Total RNA was isolated from wild-type LS-8, EV clones,
LS-8 clones derived overexpressing higher (S) and lower
(AS) levels of Wnt5a by using the RNeasy kit (Qiagen,
Valencia, CA). Two micrograms of total RNA was used for
RT by using the SuperArray Reaction Ready First Strand
cDNA Synthesis Kit (SA Bioscience, Frederick, MD) con-
taining random primers following the instructions pro-
vided in the user’s manual. Real-time PCR was performed
by using the RT2 SYBR Green/ROX qPCR Master Mix (SA
Bioscience) and sequence specific primers (SA Bio-
science). The primers used were as follows: Wnt5a (num-
ber Mm.287544) and Gapdh (number Mm.343110). Real-
time PCR was performed on an ABI 7500 Real-Time PCR
System (Applied Biosystems, Foster City, CA) by using
the following cycling parameters: 10 minutes at 95°C; 40
cycles of 15 seconds at 95°C; and 1 minute at 60°C. Dis-
sociation curve analyses were performed by using the in-
strument’s default setting immediately after each PCR run.
Cell Proliferation Assay
LS-8, EV, S, and AS clones were seeded at a density of
1  105 cell/well and maintained in DMEM containing
10% FBS for 7 days. Cells were trypsinized and counted
at days 1, 3, 5, and 7. Three independent experiments
were performed.
Growth Transformation Assays
Serum dependence of cells for growth was determined
as described previously.23 Briefly, LS-8, EV, S, and AS
clones were seeded at a density of 1  105 cell/well and
maintained in DMEM containing 10% FBS and allowed to
adhere to the culture dish. Then, culture medium was
changed to DMEM containing 1% FBS and cells were
cultured for 7 days. Cells were trypsinized and counted at
days 1, 3, 5, and 7.
To determine the ability of transfected cells to grow as
multiple layers and form foci, focus formation assay was
performed as previously described with modification.23
LS-8, EV, S, and AS clones were seeded in triplicate of
1  105 cell/60-mm cultured dish and maintained for 3
weeks. After that, cells were fixed with 3:1 (v/v) methanol:
acetic acid, stained with 0.4% crystal violet in 20% eth-
anol, and photographed. Stained foci were counted to
quantify the transforming activity.
To determine the anchorage-independent growth, soft
agar assay was performed as previously described with
modification.23 LS-8, EV, S, and AS clones were cultured
and trypsinized to obtain single-cell suspensions. A total
of 5  103 cells were suspended in DMEM containing
0.3% agar and were then seeded onto a 0.5% agar base
in six-well plates. DMEM containing 10% FBS was added
to the top of the agar and was replaced twice weekly.
Colony growth was assayed at 4 weeks after the initial
seed. The number of colonies larger than 50 m in diam-
eter (containing 30 cells per colony) was counted in five
random three-dimensional fields per well and photo-
graphed under 4 objective lens.
In Vivo Tumor Formation
To evaluate the tumorigenicity of the transfected cells, EV
cells or cells highly overexpressing WNT5A (SH) were
injected subcutaneously into the flanks of athymic nude
mice (Jackson Labs, Bar Harbor, ME) at seeding densi-
ties of 2  106 cells per site. Tumor development was
monitored at an animal studies core facility (Lineberger
Comprehensive Cancer Center, University of North Caro-
lina, Chapel Hill, NC). Tumor measurements in three di-
mensions (length  width  depth) were taken by cali-
pers three times per week over 12 weeks or until the
tumor burden reached a volume of 1 cm3. At this point,
tumors were excised immediately following euthaniza-
tion, divided in half, and fixed in 10% buffered formalin for
histological analysis or RNA-later solution (Ambion, Aus-
tin, TX) for RT-PCR. For histological analysis, tumors were
embedded in paraffin and stained with H&E. For RT-PCR
analysis, total RNA was isolated from each tumor by
using TRIzol reagent (Invitrogen). cDNA was synthesized
by using the Superscript RT kit (Invitrogen) followed by
PCR. For WNT5A overexpressing tumors, PCR was per-
formed by using T7 promoter (5-TAATACGACTCACTAT-
AGGG-3) and Wnt5a (5-TTTGCACACGAACTGATC-
CAC-3) specific primers. For tumors formed by the EV
group, PCR was done by using T7 promoter (5-TAAT-
ACGACTCACTATAGGG-3) and Bovine Growth Hor-
mone (5-CTAGAAGGCACAGTCGAGGCT-3) primers.
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Wound Healing Assay
Cells were grown on fibronectin (Sigma-Aldrich) coated
60-mm dish supplemented with completed medium (10%
FBS). After the cells reached 90% confluence, the me-
dium was switched to 2.5% FBS and a wound was cre-
ated by scratching a line across the monolayer of cells
with a pipette tip.24 The number of cells migrating in to the
space at 24 hours were counted in five random fields per
group, photographed, and fixed with 3:1 (v/v) methanol:
acetic acid, and stained with 0.4% crystal violet in 20%
ethanol. Five independent experiments were performed
with two replicates.
Actin Filament Staining
To visualize the change in actin filament organization,
cells were grown on fibronectin coated glass coverslips,
rinsed, and fixed with 4% paraformaldehyde in PBS for 10
minutes at 4°C. Next, cells were permeabilized in 0.1%
Triton X-100 in PBS for 10 minutes at 4°C. Actin filaments
were stained with a 50 g/ml of fluorescein isothiocya-
nate phalloidin (Sigma-Aldrich) in PBS for 1 hour at
room temperature. The nuclei were counterstained with
TOPRO-3 dye (Invitrogen). Fluorescent images were ex-
amined with Olympus FluoView FV500 confocal fluores-
cent microscope (Olympus Inc., Center Valley, PA).
Statistical Analysis
Statistical analyses in all experiments, except the immu-
nohistochemistry, were performed by using Sigma stat
software (Systat Software Inc., San Jose, CA). Data were
presented as mean  SD. Statistical differences were
determined by one-way analysis of variance followed by
a Tukey-Kramer multiple comparison test at P  0.05. For
immunohistochemical analysis, ameloblastoma samples
were categorized into positive and negative groups,
based on expression of WNT5A, and were then com-
pared in regard to each clinicopathological variable in-
cluding age, gender, tumor location, and histological
types. The 2 test was used for statistical analysis and
P  0.05 was considered to be statistically significant.
Results
Expression of WNT5A in Ameloblastoma
We validated the specificity and sensitivity of anti-
WNT5A antibody before using it in further experiments.
Strong WNT5A expression was detected in mouse small
intestine and hair follicle (Supplemental Figure 1, A and
C, see http://ajp.amjpathol.org) since WNT5A is essential
for mouse small intestine elongation and hair follicle de-
velopment.25,26 As previously reported,27 weak or absent
WNT5A expression was observed in adult mouse liver
(Supplemental Figure 1E, see http://ajp.amjpathol.org).
The results of immunohistochemistry demonstrated the
presence of WNT5A in ameloblastomas (Figure 1A). The
epithelial nests and/or strands exhibited strong positive
staining. Slight WNT5A expression was also detected in
the stromal component of ameloblastomas. WNT5A im-
munoreactivity in ameloblastoma was confirmed since
the staining in both epithelium and stroma was absent
when anti-WNT5A antibody was blocked with a recombi-
nant WNT5A protein.
Figure 1. Expression of WNT5A in ameloblas-
toma and during human tooth development. A:
Ameloblastomas were immunostained with anti-
WNT5A antibody (1:200) and images were cap-
tured under 100 magnifications. Sections incu-
bated with normal horse serum and recombinant
WNT5A (rWNT5A) (2 g/ml) blocked antibody
were used as negative controls. Scale bar  100
m; n  52. B: At the cap stage, WNT5A was
localized in both outer (OE) and inner enamel
epithelium (IE) but weakly detected in dental mes-
enchyme (DM). During the early bell stage,
WNT5A remained in IE and presecretory amelo-
blasts (PAM) with intense expression around
enamel knots (EK) and cervical loops (CL). At the
late bell stage, WNT5A expression remained in
EK and CL but was absent from mature or secre-
tory ameloblasts (MAM), as well as dental papilla
(DP) and developing odontoblasts (OD). Scale
bar  50 m; n  3. Arrows identify structures
and cells defined by abbreviations.
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Among 52 samples of first occurrence, solid/multicys-
tic ameloblastoma, we found the major histological pat-
tern of the tumors was the mixture of plexiform and fol-
licular patterns (44%), followed by follicular (29%) and
plexiform (27%) patterns. Expression of WNT5A was ob-
served in 46 ameloblastomas (88%) regardless of the
variation in histological subtype. We detected compara-
ble levels of WNT5A expression among histologically
different ameloblastoma patterns. Negative WNT5A ex-
pression was found in six cases (12%) and the major
subtype of these ameloblastomas was the mixed plexi-
form and follicular pattern (67%). We were able to retrieve
the clinicopathological features of tumors from 34 cases,
and the data along with statistical analysis are shown in
Table 1. Statistical analysis showed no significant corre-
lation between WNT5A expression in ameloblastomas
and any variables, such as age, gender, tumor location,
and histological subtypes.
Expression of WNT5A during Human Enamel
Epithelium Development
To better understand the possible role of WNT5A in
odontogenic tumors, we performed immunohistochem-
ical analysis of the WNT5A expression during the de-
velopment of normal human teeth (Figure 1B). Human
molars at cap stage (13 to 16 gestational weeks)
showed WNT5A localized in both outer and inner
enamel epithelium but was weakly detected in dental
mesenchyme. During early bell stage (16 to 18 gesta-
tional weeks), WNT5A expression was maintained in
the inner enamel epithelium, outer enamel epithelium,
and presecretory ameloblasts with intense expression
around the enamel knot and cervical loop. At late bell
stage (18 to 20 gestational weeks) when there was
some deposition of enamel matrix, WNT5A expression
remained in the enamel knot and cervical loop but was
absent from secretory ameloblasts as well as dental
papilla and developing odontoblasts.
Establishment and Characterization of LS-8
Derived Stable Clones
To determine the biological consequences of WNT5A
expression in enamel epithelium, we overexpressed or
underexpressed WNT5A in LS-8 cells. Full-length mouse
Wnt5a constructs were generated and verified as bands
at the expected size at 1140 bp (Supplemental Figure 2,
see http://ajp.amjpathol.org). The Wnt5a-PCR products
were then ligated into pcDNA3.1 V5-His-TOPO mamma-
lian expression vector. We stably transfected LS-8 cells
with sense (pcDNA3.1/Wnt5a) or antisense (pcDNA3.1/
ASWnt5a) constructs, and stable clones were selected in
the presence of G418 (600 g/ml) in 4 to 5 weeks after
transfection. The EV clones (pcDNA3.1/V5-His B) were
subjected to the same selection procedure and were
used as controls. To ensure the secretion of WNT5A,
expression of WNT5A into the conditioned medium gen-
erated from each stable clone was verified by Western
blot. Due to WNT5A’s highly hydrophobic nature, we
adopted the Triton X-114 phase separation technique to
concentrate and maintain solubility of WNT5A in condi-
tioned medium.21,22 Results shown in Figure 2A illustrate
that most secreted WNT5A partitioned to the detergent
phase (De). Bands at the size of 42 kDa (asterisks in
Figure 2A) represented endogenous WNT5A expressed
in LS-8 (wild-type), S, and EV clones, while it disap-
peared from AS clone. Bands at approximately 47 kDa
(arrow in Figure 2A) represented WNT5A recombinant
proteins that were only expressed in sense transfected
clones and confirmed the production of WNT5A from
transfected constructs. Faint staining bands were seen at
47 kDa in the EV and wild-type cells and higher molec-
ular weight bands in all cells representing weak bind-
ing to non-WNT5A proteins.
When comparing the expression of WNT5A collected
from cell surface and cell matrices, the level of WNT5A from
S clones was classified into the following three groups: high;
moderate; and low overexpression (SH, SM, and SL clones)
as shown in Figure 2B. The endogenous WNT5A expres-
sion in EV clones was comparable with wild-type, while it
was suppressed in AS stable clones (Figure 2C). Expres-
sion of Wnt5a in each selected clone was then quantified by
real-time PCR (Figure 2D). Average expressions of Wnt5a in
SH, SM, and SL clones showed 7.97, 4.5, and 2.3 fold
increases respectively when compared with wild-type and
EV clones. Wnt5a expression was decreased in selected
AS clones by 0.13-fold. Three independent clones from
each transfection were selected for next experiments.
Effects of WNT5A on In Vitro Cell Growth
Transformation of Enamel Epithelium
We next evaluated the growth properties of selected
stable clones by in vitro cell growth transformation assay.
EV, S, and AS clones showed similar morphology to
wild-type (Figure 3A). Increased expression of WNT5A in
enamel epithelium did not affect cell proliferation when
cells were maintained in medium containing 10% FBS
(Figure 3B). Interestingly, when cultured in serum-re-
Table 1. Clinicopathological Features of Ameloblastoma in
Relation to WNT5A Expression
Variables n WNT5A WNT5A	 2 0.05
Age, yr 34 30 4 0.78
0–20 9 8 1 —
20–40 13 12 1 —
40 12 10 2 —
Sex 34 30 4 0.92
Male 18 16 2 —
Female 16 14 2 —
Tumor location 34 30 4 0.73
Maxilla 11 10 1 —
Mandible 23 20 3 —
Histological types 52 46 6 0.53
Follicular 15 14 1 —
Plexiform 14 13 1 —
Mixed 23 19 4 —
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duced condition that contained 1% FBS, only the WNT5A
overexpressing clones survived in the serum-starved
condition. S clones had dramatically decreased prolifer-
ation rates but survived up to 7 days in culture while
wild-type, EV, and AS clones did not survive under re-
duced serum conditions (Figure 3C). This result sug-
gested that WNT5A could promote less dependence of
growth factor property on enamel epithelium.
WNT5A overexpressing clones also exhibited loss of
contact inhibition of growth after confluence when tested
with focus formation assay. Allowing growth beyond conflu-
ence, SH, SM, and SL clones formed multilayered of foci on
culture dishes for up to 20 days (Figure 4A). Few foci were
found in wild-type, EV, and AS clones. Numbers of foci
formed by WNT5A overexpressing clones were correlated
with the level of WNT5A expression (Figure 4B) suggesting
that WNT5A could promote loss of contact inhibition in
enamel epithelium in a dose dependent manner.
Next, we analyzed anchorage-independent of growth in
these clones by soft agar assay. S clones formed visible
colonies within 2 weeks after seeding (Figure 4C), whereas
wild-type, EV, and AS clones did not form colony visible by
bare eyes even after 4 weeks of culture. Similar to what we
found in foci formation, the numbers of colony formed in soft
agar by WNT5A overexpressing clones corresponded to
their level of WNT5A expression (Figure 4D).
Finally, we determined if WNT5A overexpression could
affect the tumorigenicity of LS-8 cells when subcutane-
ously transplant into nude mice. SH cells formed palpa-
ble tumors (approximately 0.2  0.2  0.2 cm3) in the
mice within 4 days after injection (Figure 5A). Interest-
ingly, EV cells also exhibited tumor formation at 18 days
after injection. After monitoring for up to 48 days, all mice
in the experiment developed tumors; however, SH cells
appeared to develop tumors earlier than EV control cells.
On average, mice injected with SH cells exhibited tumors
within 18 days post implantation in contrast to the EV
controls that developed tumors in 32 days. SH cells also
had a faster tumor growth rate compared with the EV
group when total tumor volume was calculated (Figure
5B). All tumors were solid masses, nonencapsulated
but well circumscribed by peripheral connective tissue
stroma. Connective tissue infiltrating area was rarely seen
in these tumors. Histology of the tumors from both groups
appeared to be similar (Figure 5C). They both were com-
posed of a mixture of epithelium and mesenchyme. The
tumors did not display a typical ameloblastoma-like his-
tological appearance but did develop duct-like or follic-
ular structures (arrow in Figure 5C) formed by cuboidal
epithelium that were randomly distributed in the tumor
with mesenchymal cells making up the majority of the tu-
mor. Most of the mesenchymal cells were fibroblast-like,
poorly differentiated, andwere in activemitosis as shown by
dense chromatin condensation. No calcifying areas or
tooth-forming structure were observed in any of the tumors.
We performed RT-PCR to confirm the origin of the tu-
mors. For tumors formed by SH cells, PCR using T7 forward
and Wnt5a reverse primers generated the products ap-
proximately 1150 bp of the transfected and integrated
Wnt5a plasmid (Supplemental Figure 3A, see http://
ajp.amjpathol.org). For tumors formed by EV group, PCR
using T7 forward and Bovine Growth Hormone reverse
primes yielded the 250 bp bands of integrated pcDNA3.1
V5-HisA empty vectors (Supplemental Figure 3B, see http://
ajp.amjpathol.org). The detection of these PCR products
indicated that tumors formed in nude mice were devel-
Figure 2. Level of WNT5A production from different transfection. A: Se-
creted Wnt5a in conditioned medium was partitioned in detergent phase
(De) but not aqueous phase (Aq) after Triton X-114 phase separation. The 42
kDa band of endogenous WNT5A (asterisks) was faintly visible in wild-type
(WT), overexpressed (S) and empty vector (EV) transfections. The 47 kDa
band of WNT5A fusion protein (arrow) was only detected in S transfected
clones while WNT5A production was suppressed in AS transfections. B:
Stable clones established from S transfection were selected and categorized
according to level of expression in to high (SH), moderate (SM), and low (SL)
overexpressing WNT5A clones. C: The endogenous Wnt5a (42 kDa) in EV
clones was comparable with wild-type, while it was suppressed in AS stable
clones. Cell lysate from NIH3T3 cell was used as a negative control. Three
independent clones from each S group, together with EV and AS clones were
selected for further experiments. D: Quantification of Wnt5a expression in
selected stable clones by real-time PCR. Selected stable clones from S transfec-
tion showed increase in Wnt5a expression compared with wild-type and EV
clones, 2.37-, 4.5-, and 7.97-fold increase in SL, SM, and SH respectively.Wnt5a
expressions in stable clones from AS transfection were decreased by 0.13-fold.
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oped from injected enamel epithelium and not from the
indigenous mouse cell populations.
WNT5A Increased Cell Migration and Actin
Polymerization of Enamel Epithelium
Since WNT5A activation has been shown to promote cell
migration,11 we examined whether WNT5A could induce
actin filament rearrangement to regulate cell migration in
enamel epithelium. A scratch wound was created on 90%
of confluent monolayer of cells in culture medium con-
taining 2.5% FBS to stimulate cell migration (Figure 6A).
At 17 hours after scratching, the highest numbers of cells
migrating into the created wounds were from S clones,
moderate numbers from wild-type and EV and fewest
numbers from AS clones. At 24 hours, cells from S clones
were able to close the wound (Figure 6B). Although ad-
ditional cells from wild-type and EV migrated to the space
when compared with the results at 17 hours, they did not
close the wound. Interestingly, only small number of cells
from AS clones migrated into the created wound sug-
gesting that WNT5A regulated enamel epithelium cell
migration.
Since the change in stress fiber formation is a necessary
process in cell migration,28–30 we evaluated the role of
WNT5A in this process by actin filament staining. Cells were
plated on fibronectin coated coverslips. Actin cytoskeleton
was stained by using fluorescein isothiocyanate phalloidin
(Figure 6C). Consistent with the results of our cell migration
assay, stress fiber formation density was greatly increased
in the cells from S clones, but largely decreased in the cells
from AS clones, when they were compared with EV cells.
Interestingly, filopodia and lamellipodia, structures both
of which are important for cell migration, were gener-
ally seen in WNT5A overexpressing cells (Figure 6, C
and D), while WNT5A underexpressing cells appeared
to form clusters with migratory structures rarely being
seen. These results confirm that WNT5A induces
enamel epithelium cell migration and this process in-
volves actin cytoskeleton reorganization.
Discussion
Our study demonstrated that ameloblastomas are highly
consistent in their expression of WNT5A. While WNT5A
Figure 3. Cell morphology and proliferation assay of stable clones. A: No significantly different morphology was observed among wild-type (WT), EV, S, and AS
clones. When recombinant WNT5A (rWNT5A) (0.25 g/ml) was added to the culture medium, WNT5A treated LS-8 showed similar phenotype to wild-type. B:
1  105 cells WNT5A from each clone were plated and supplemented with medium containing 10% FBS. Proliferation rates were similar among all groups. C:
When the same number of cells were cultured in 1% FBS medium, sense clones had a dramatically decreased proliferation rate but still survived in serum-reduced
condition up to 7 days of culture. Wild-type, EV, and AS clones could not survive under these conditions. Original magnification, 200. Scale bar  100 m.
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expression is often associated with malignant tumors,
ameloblastomas are benign but highly invasive tumors.
Detection of WNT5A expression in granular cell amelo-
blastoma has been suggested by others,19 but for the
first time our study reports the molecular consequences
of WNT5A signaling activation in enamel epithelium cell.
In the present study, it is notable that comparable
levels of WNT5A expression were found in the plexiform,
follicular and mixed plexiform/follicular histological sub-
types, the two most common variants of ameloblastoma.
Interestingly, our study finds no statistically significant
relationship between WNT5A expression and clinicopath-
ological or demographic features. One possible reason
for this result could be due to the relative consistency of
tumor variety in our sample since the recurrence and/or
malignant ameloblastomas are excluded. The authors of
future studies evaluating recurrent ameloblastomas should
investigate the distribution and level of WNT5A expression.
Unfortunately the aggressiveness of ameloblastomas is not
evaluated since all samples are graded as benign tumors
and they are typically removed immediately following diag-
nosis.3,5,31 Although there is a difference in occurrence
rates observed between subtypes, authors report no corre-
lation among each histologically different pattern and ag-
gressiveness of ameloblastoma.4,5,31
Enamel epithelial remnants from migrating enamel ep-
ithelium in the cervical loops are believed to give rise to
odontogenic tumors. Interestingly, WNT5A expression in
ameloblastoma is also intense in the epithelial compart-
ment, which is similar to WNT5A detection in cervical
loop. In the cancer stem cell theory, we know that many
cancer cells display a stem-cell like phenotype. The re-
sult of cervical loop cells strongly expressing WNT5A
provides further support for the assumption that enamel
epithelium remnants from cervical loop are the cell of
origin for odontogenic tumors.
One major difficulty in studying the molecular pathol-
ogy of odontogenic tumors is the lack of appropriate cell
lines and animal models. For the cell origin of odonto-
genic tumors, LS-8 cell exhibits several characteristics
including the expression of enamel matrix genes, such as
amelogenin and ameloblastin, making it suitable for these
studies.20,32 LS-8 cells are the most widely use in vitro
model to study enamel epithelium biology and gene reg-
Figure 4. WNT5A promoted loss of contact inhibition and anchorage-independent growth in
enamel epithelium. A: SH, SM, and SL formed multilayered foci on culture dishes after being
cultured for 3 weeks while few foci formations were found in wild-type (WT), EV, or AS
clones. B: Numbers of foci formation were correlated with the level of WNT5A expression in
overexpressed clones suggesting dose dependent effect. C: S clones formed visible colonies
in soft agar within 2 weeks after seeding, whereas wild-type, EV, and AS clones failed to form
visible colonies by bare eyes. D: The number of colonies formed by S clones corresponded
to the level of WNT5A expression. Original magnification 40. Scale bar  200 m. *P  0.05
vs EV, **P  0.05 vs. SH.
468 Sukarawan et al
AJP January 2010, Vol. 176, No. 1
ulation of ameloblast development.32–35 Since LS-8 cells
are immortalized by Simian virus 40 large T antigen, the
interpretation of our results should be done with some
caution. Interestingly, we observed in in vivo tumor forma-
tion assays that LS-8 cell populations had already ac-
quired some growth transformation properties. Although
wild-type LS-8 and EV cells form fewer colonies in soft
agar and tumors in nude mice, statistically significant
differences were observed with S cells that showed ro-
bust activities in all cell growth transformation assays. In
the in vivo tumor formation assay, SH cells formed tumors
2 weeks earlier and exhibited faster tumor growth rates
compared with EV cells. These phenomena could be
partly explained by the potential function of WNT5A as an
oncogenic enhancer. LS-8 cells potentially obtained
some tumorigenicity from Simian virus 40 large T antigen,
and WNT5A, therefore, enhances tumorigenicity of these
cells. WNT5A was categorized as nontransformed WNT
due to the inability to transform mammary epithelial
cells,36,37 but its transforming property has rarely been tested
in other cell models. In fact, WNT5A signaling outcomes are
largely dependent on receptors availability.11,38 More recently,
the line of evidence leans toward the fact that the major role of
WNT5A in cancer is to promote the aggressiveness of cancer
cells rather than cancer initiation.11 Our observations from cell
growth transformation assays also suggest that WNT5A func-
tions as an enhancer to increase the oncogenic properties in
LS-8 cells. Whether WNT5A can function as an oncogenic
transformer is still inconclusive.
It is notable that histology of the tumors formed in both
groups appears to be similar with the bulk of the cells
being mesenchymal even though the cells being injected
were epithelial. RT-PCR showed that these tumors devel-
oped from the injected enamel epithelium cells since the
integrated empty vector and Wnt5a plasmids were de-
tected from tumor RNA. It is possible that the LS-8 cells
could have undergone epithelium-mesenchyme transi-
tion. Additionally, WNT5A has been associated with the
loss of E-cadherin and epithelium-mesenchyme transition
expression in squamous cell carcinoma.39 Another possible
explanation is based on the fact that enamel epitheliums are
able to induce proliferation and differentiation of surround-
ing mesenchyme (odontoblast during tooth development).
LS-8 cells might induce improper proliferation and differen-
tiation of surrounding mesenchyme and secreted WNT5A
from LS-8 cells could function in a paracrine manner to help
accelerate this process. Although the histology of these
tumors differed from the typical ameloblastoma and the
area of tooth forming-like structure was not observed, this
result was not surprising. Since the environment at the in-
oculating sites was considerably different from the
jaws, the lack of reciprocal dental related cells could
explain this finding. Injection of LS-8 cells into the jaw
area should be considered in future experiments to
create a potentially more appropriate environment for
odontogenic tumor development.
The function of WNT5A in cell migration is another
controversial subject evaluated by our studies. WNT5A
suppresses migration and invasion of breast epithelial
cells.40,41 On the other hand, WNT5A increases cell mi-
gration and invasion in melanoma cell, fibroblast, and
breast cancer.12,42,43 In our study, we found that WNT5A
drastically promoted cell migration in LS-8 cells. This
effect was due to increased cell migration rather than cell
proliferation since the experiment was done in cultured
medium containing 2.5% FBS and WNT5A had no effect
on LS-8 cells when tested with the cell proliferation assay.
Cells overexpressing WNT5A also exhibited actin rear-
rangement and formed lamellipodia and filopodia at the
edges of the cells. When endogenous WNT5A was sup-
pressed, AS cells failed to form significant actin reorga-
nization and membrane protrusion was rarely seen.
Therefore, our data indicate a role for WNT5A in regulat-
Figure 5. Tumor formation in nude mice. WNT5A overexpressing (SH) or
EV-LS-8 cells (2  106) were subcutaneously transplanted into nude mice
(n  8 per group). A: SH cells formed tumors within 4 days after injection.
EV groups also exhibited tumor growth at 18 days. In average, SH cells
exhibited tumors within 18 days post implantation compared with 32 days in
the EV group. B: SH groups also showed faster tumor growth rates when total
tumor volume was calculated. Tumor formation was monitored for up to 83
days. C: H&E staining of tumors formed in nude mice. Tumors histology
appeared similar in both groups. The majority of the tumor mass comprised
of mesenchyme with epithelium that randomly formed a duct-like structure
(arrows). Scale bar  50 m; n  8.
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ing enamel epithelium cell motility by increasing actin
reorganization and extension that generates the force for
cell movement.
The fact that WNT5A is shown to promote cancer
aggressiveness and metastasis in many types of can-
cer could suggest the possible role of WNT5A in
ameloblastoma progression. In melanoma, WNT5A
was predominantly detected in the leading front of
cancer invasion while other areas showed weaker ex-
pression,12 suggesting the effect of differential WNT5A
expression on tumor cell behavior. This could be ex-
trapolated to the slow growing nature of ameloblasto-
mas that might be regulated by the temporal WNT5A
expression where tumors actively grow when WNT5A is
expressed, and the tumor cells are in resting stage
when WNT5A expression is down-regulated. In sum-
mary, our results demonstrate that WNT5A overexpres-
sion has multiple effects on enamel epithelial cells.
WNT5A has the effect of promoting cell survival, instill-
ing a loss of contact inhibition and loss of anchorage
dependence, and allowing an increase in cell migra-
tion, which are all important characteristics of tumori-
genic cells. Taken together, this knowledge strongly
suggests the importance of WNT5A during ameloblas-
toma development and inhibition of WNT5A signaling
could possibly serve an effective therapeutic approach
to preserve the jaw from radical excision treatment and
prevent the recurrence of this tumor.
Figure 6. WNT5A increased cell migration in enamel
epithelium cells. A: 2  106 of cells were seeded onto the
fibronectin coated 60-mm dish and supplemented with
2.5% FBS in DMEM. A scratch was made and cell migra-
tion into the space was monitored at 17 and 24 hours.
WNT5A overexpressing cells (S) showed enhanced mi-
gration compared with EV control. In contrast, WNT5A
underexpressing cells (AS) had greatly decreased cell
migration. B: The number of migrated cells in to the
space was quantified from five random fields. Original
magnification 100; scale bar  100 m. *P  0.05 vs
EV. C: Actin cytoskeleton was stained by using fluores-
cein isothiocyanate phalloidin (bright) and examined by
using confocal microscopy. WNT5A overexpressing (S)
cells showed a greatly increased density of stress fiber
formation when compared with EV and AS cells. Filop-
odia and lamellipodia (arrows) were generally seen in
WNT5A-S. D: The number of filopodia/lamellipodia was
counted and shown as mean  SD value from 20 cells/
group. Original magnification 600; scale bar  20 m.
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